Stay updated on ZYN002 Long-Term Safety in Children with FXS Clinical Trial
Sign up to get notified when there's something new on the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page.

Latest updates to the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about the ZYN002 study and its administration for Fragile X Syndrome, while introducing a new revision number and the term 'Open-Label'.SummaryDifference31%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 19, 2025. However, the removal of the date March 25, 2025, does not significantly impact the core content.SummaryDifference0.4%
- Check73 days agoChange DetectedThe page has been updated to reflect a new open-label extension study for ZYN002 in children and adolescents with Fragile X Syndrome, with changes in the study's duration, number of locations, and age range of participants.SummaryDifference5%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to ZYN002 Long-Term Safety in Children with FXS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZYN002 Long-Term Safety in Children with FXS Clinical Trial page.